Moderna seeks full FDA approval for its vaccine

Moderna announced Tuesday it has begun a rolling submission to the Food and Drug Administration of data from its studies of the two-dose vaccine.

Moderna is the second COVID-19 vaccine maker to seek full approval, following Pfizer and German partner BioNTech. (File)

American pharmaceutical company Moderna says it has begun the process to win full US regulatory approval for the use of its COVID-19 vaccine in adults.

Moderna announced Tuesday it has begun a rolling submission to the Food and Drug Administration of data from its studies of the two-dose vaccine.

Moderna’s vaccine already has been cleared for emergency use by the FDA and regulators in numerous other countries. So far, more than 124 million doses have been administered in the United States.

Story continues below this ad

Large-scale studies of the shots continued after Moderna’s emergency authorization. The FDA will scrutinize the information to see if the vaccine meets stringent criteria for full licensure.

Moderna is the second COVID-19 vaccine maker to seek full approval, following Pfizer and German partner BioNTech.

Last week, Moderna also announced that its vaccine appears safe and effective in kids as young as 12. The company plans to seek emergency authorization for teen use this month.

Stay updated with the latest - Click here to follow us on Instagram

2 suspects in Louvre heist case arrested by French police: report

World1 hr ago

French police have arrested two suspects in the Louvre jewel heist, one at the airport and the other in a Paris suburb. They are currently being questioned by authorities. Paris police have not yet commented on the situation.

View all shorts

Live Blog

PHOTOS